Abstract:Our lab studies molecular determinants of vessel wall homeostasis, with particular emphasis on molecules and pathways that contribute to aortic aneurysm. The study of Marfan syndrome (MFS), an autosomal dominant condition with a strong predisposition for aortic root aneurysm and dissection, has provided a tractable means to gain a foothold in the pathogenesis of this complex phenotype. Our initial studies demonstrated that MFS is caused by mutations in the extracellular matrix protein fibrillin-1. Early pathogenetic models that singularly invoked inherent weakness of the tissues as the driving force in disease progression boded poorly for the development of productive treatment strategies and failed to reconcile multiple disease manifestations, including bone overgrowth, myxomatous valve changes, and muscle and fat hypoplasia. Using mouse models of MFS, we demonstrated that fibrillin-1 is not simply a structural protein but rather regulates the local bioavailability and activation of the growth factor transforming growth factor (TGF) β . Many important manifestations of MFS, including emphysema, valve degeneration, myopathy, and aortic aneurysm, could be attenuated or prevented in fibrillin-1–deficient mice upon systemic administration of TGF β antagonists. Similar protection was achieved through the use of the angiotensin II type 1 receptor blocker (ARB) losartan, which lowers both blood pressure and TGF β signaling and is in widespread clinical use for the treatment of hypertension. These observations led to the first clinical trial for MFS that is based upon a refined mechanistic understanding of disease. We now have performed comprehensive interrogation of a modifier network in mouse models of MFS. These data reveal parsing of the angiotensin II signaling cascades in the pathogenesis and prevention of aortic aneurysm. Signaling through the type 2 (AT2) receptor is protective, whereas loss of AT2 signaling accelerates disease and attenuates the protection afforded by ARBs, suggesting that losartan provides protection, at least in part, through shunting of angiotensin II signaling through AT2. We also demonstrate a predominant role of noncanonical TGF β signaling in the pathogenesis of ascending aortic aneurysm and show that the mechanism of AT2-mediated protection derives from cross-talk with this pathway. Taken together, these data explain why ARBs markedly outperform angiotensin-converting enzyme inhibitors in our mouse model of MFS. They also define noncanonical TGF β and AT2 signaling as prognostic and therapeutic modifiers of vascular disease and provide rationale and incentive for additional clinical trials in MFS and related disorders.

Impact of Notch3 Activation on Aortic Aneurysm Development in Marfan Syndrome

Single-Cell Transcriptomic Profiling of Vascular Smooth Muscle Cell Phenotype Modulation in Marfan Syndrome Aortic Aneurysm

Divergent effects of canonical and non-canonical TGF-β signalling on mixed contractile-synthetic smooth muscle cell phenotype in human Marfan syndrome aortic root aneurysms

Dissecting aortic aneurysm in Marfan syndrome is associated with losartan-sensitive transcriptomic modulation of aortic cells

Genetic Manipulation of Caveolin-1 in the Mouse Model of Marfan Syndrome Associated Aortic Root Aneurysm: Effects on Endothelial and Smooth Muscle Function

FN (Fibronectin)-Integrin α5 Signaling Promotes Thoracic Aortic Aneurysm in a Mouse Model of Marfan Syndrome

Abstract 15539: Single-cell Analysis of Aortic Tissues from Patients with Marfan Syndrome Reveals Changes in Smooth Muscle Cell Differentiation

Lineage-Specific Induced Pluripotent Stem Cell-Derived Smooth Muscle Cell Modeling Predicts Integrin Alpha-V Antagonism Reduces Aortic Root Aneurysm Formation in Marfan Syndrome Mice

Complement C3a/C3aR inhibition alleviates the formation of aortic aneurysm in Marfan syndrome mice

Embryologic Origin Influences Smooth Muscle Cell Phenotypic Modulation Signatures in Murine Marfan Syndrome Aortic Aneurysm

2009 George E. Brown Memorial Lecture—Marfan Syndrome and Related Disorders: From Molecules to Medicines

Sex-Dependent Effects on Endothelial and Smooth Muscle Function

Single-nucleus Multiomic Analyses Identifies Gene Regulatory Dynamics of Phenotypic Modulation in Human Aneurysmal Aortic Root

Aortic and Cardiac Structure and Function Using High-Resolution Echocardiography and Optical Coherence Tomography in a Mouse Model of Marfan Syndrome

Aortic Dimensions, Biophysical Properties, and Plasma Biomarkers in Children and Adults with Marfan or Loeys-Dietz Syndrome

Age- and sex-specific biomechanics and extracellular matrix remodeling of the ascending aorta in a mouse model of severe Marfan Syndrome

Effects of Age, Sex, and Extracellular Matrix Integrity on Aortic Dilatation and Rupture in a Mouse Model of Marfan Syndrome

Inhibition of IL11 Signaling Reduces Aortic Pathology in Murine Marfan Syndrome

Versican accumulation drives Nos2 induction and aortic disease in Marfan syndrome via Akt activation

PIEZO1 Attenuates Marfan Syndrome Aneurysm Development Through TGF-β Signaling Pathway Inhibition Via TGFBR2

Fibroblast-Secreted Phosphoprotein 1 Mediates Extracellular Matrix Deposition and Inhibits Smooth Muscle Cell Contractility in Marfan Syndrome Aortic Aneurysm